Detalhe da pesquisa
1.
Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006.
Br J Cancer
; 119(6): 670-674, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30202085
2.
Impact of stimulation duration and gonadotropin type on the incidence of premature progesterone elevation - a retrospective analysis of the Ensure data.
Gynecol Endocrinol
; 34(12): 1044-1047, 2018 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-29890865
3.
Does moderate renal impairment affect clinical outcomes in complicated intra-abdominal and complicated urinary tract infections? Analysis of two randomized controlled trials with ceftolozane/tazobactam.
J Antimicrob Chemother
; 72(3): 900-905, 2017 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27999024
4.
Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam.
BMC Infect Dis
; 17(1): 316, 2017 05 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28464828
5.
Infections during peginterferon/ribavirin therapy are associated with the magnitude of decline in absolute lymphocyte count: results of the IDEAL study.
Clin Infect Dis
; 58(7): 960-9, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-24399086
6.
Analysis of site performance in academic-based and community-based centers in the IDEAL Study.
J Clin Gastroenterol
; 47(10): e91-5, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-23787248
7.
Efficacy and safety of elbasvir/grazoprevir for 12 weeks in people with hepatitis C virus infection aged 35 years or younger compared with older people: a retrospective integrated analysis.
Curr Med Res Opin
; 36(8): 1325-1332, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32459122
8.
Elbasvir/grazoprevir in women with hepatitis C virus infection taking oral contraceptives or hormone replacement therapy.
Int J Womens Health
; 11: 617-628, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31819666
9.
Ceftolozane/tazobactam dose regimens in severely/morbidly obese patients with complicated intra-abdominal infection or complicated urinary tract infection.
Int J Antimicrob Agents
; 52(3): 324-330, 2018 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-29596902
10.
Efficacy and Safety of Sitagliptin in Hispanic/Latino Patients with Type 2 Diabetes: A Pooled Analysis from Ten Randomized, Placebo-Controlled Phase 3 Clinical Trials.
Diabetes Ther
; 9(4): 1581-1589, 2018 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-29936573
11.
Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia.
World J Hepatol
; 8(6): 331-9, 2016 Feb 28.
Artigo
Inglês
| MEDLINE | ID: mdl-26962399
12.
Long-term follow-up of patients receiving boceprevir for treatment of chronic hepatitis C.
Antiviral Res
; 113: 71-8, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25446895
13.
Clinical Implications of Detectable Baseline Hepatitis C Virus-Genotype 1 NS3/4A-Protease Variants on the Efficacy of Boceprevir Combined With Peginterferon/Ribavirin.
Open Forum Infect Dis
; 1(2): ofu078, 2014 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-25734146
14.
Analysis of boceprevir resistance associated amino acid variants (RAVs) in two phase 3 boceprevir clinical studies.
Virology
; 444(1-2): 329-36, 2013 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-23876458
15.
Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patients.
J Acquir Immune Defic Syndr
; 54(5): 470-6, 2010 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-20672447
16.
Virologic and immunologic activity of PegIntron in HIV disease.
AIDS
; 23(18): 2431-8, 2009 Nov 27.
Artigo
Inglês
| MEDLINE | ID: mdl-19898218
17.
Phase II study of vicriviroc versus efavirenz (both with zidovudine/lamivudine) in treatment-naive subjects with HIV-1 infection.
J Infect Dis
; 198(8): 1113-22, 2008 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-18783318